{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Introduction to Changing Conversations",
      "startTime": 37.22,
      "endTime": 100.26
    },
    {
      "title": "New Questions on GLP-1 Meds",
      "startTime": 100.26,
      "endTime": 263.82
    },
    {
      "title": "Understanding Anhedonia",
      "startTime": 263.82,
      "endTime": 639.44
    },
    {
      "title": "Addiction and GLP-1 Medications",
      "startTime": 639.44,
      "endTime": 801.83
    },
    {
      "title": "The Impact of GLP-1s",
      "startTime": 801.83,
      "endTime": 863.23
    },
    {
      "title": "The Rise of Oral Medications",
      "startTime": 863.23,
      "endTime": 1123.56
    },
    {
      "title": "The Challenge of Adherence",
      "startTime": 1123.56,
      "endTime": 1377.01
    },
    {
      "title": "Microdosing: The New Trend",
      "startTime": 1377.01,
      "endTime": 1517.58
    },
    {
      "title": "Exploring Microdosing Data",
      "startTime": 1517.58,
      "endTime": 1699.27
    },
    {
      "title": "The Concept of Food Noise",
      "startTime": 1699.27,
      "endTime": 1915.06
    },
    {
      "title": "The Reality of Ozempic Face",
      "startTime": 1915.06,
      "endTime": 2156.59
    },
    {
      "title": "Addressing Hair Loss Concerns",
      "startTime": 2156.59,
      "endTime": 2306.02
    },
    {
      "title": "Non-Responders vs. Super Responders",
      "startTime": 2306.02,
      "endTime": 2492.12
    },
    {
      "title": "The Need for More Medications",
      "startTime": 2492.12,
      "endTime": 2846.62
    },
    {
      "title": "Balancing Medical and Social Solutions",
      "startTime": 2846.62,
      "endTime": 2902.4
    },
    {
      "title": "Conclusion and Future Questions",
      "startTime": 2902.4,
      "endTime": 3025.87
    }
  ]
}